Close Menu

cell-based assays

The firm will use its in vitro transporter technology platform to examine drug-dietary supplement interactions.

The German-based company expects to file its test for FFPE within the next few months, and to start a clinical trial for its cytology test by mid-year.

In return for access to Forma's compound library and cell-based screening platforms, Eisai will pay $20 million upfront and in committed funding over three years, plus potential milestone and royalty payments.

The firms have expanded an alliance to include cell culture media and high-performance toxicity assays for new cell-based tools for drug discovery and development.

The new label-free and real-time cell-based assays will incorporate Vivo's HuBiogel platform.

A new NINDS and NIMH grant program will provide up to $5 million in grants to develop scalable assays for analysis of molecular and cellular events in neurons related to brain functioning.

Berlin-based Probiogen will provide its Human Artificial Lymph Node Technology to Affiris to search for vaccine candidates for potential clinical trials.

The high-throughput and assay development agreement will focus on identifying and validating hits for an immune disease and cancer-related target.

ZenBio will offer the cell lines in cryopreserved and cultured forms, as well as contract services including assay development and compound screening.

The companies will develop miniaturized cell-based assays using high-throughput flow cytometry and computational models for hepatotoxicity testing.


Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.